206 related articles for article (PubMed ID: 18727058)
41. Cisplatin resistance induced in germ cell tumour cells is due to reduced susceptibility towards cell death but not to altered DNA damage induction or repair.
Fenske AE; Glaesener S; Bokemeyer C; Thomale J; Dahm-Daphi J; Honecker F; Dartsch DC
Cancer Lett; 2012 Nov; 324(2):171-8. PubMed ID: 22613583
[TBL] [Abstract][Full Text] [Related]
42. Evidence for the involvement of double-strand breaks in heat-induced cell killing.
Takahashi A; Matsumoto H; Nagayama K; Kitano M; Hirose S; Tanaka H; Mori E; Yamakawa N; Yasumoto J; Yuki K; Ohnishi K; Ohnishi T
Cancer Res; 2004 Dec; 64(24):8839-45. PubMed ID: 15604242
[TBL] [Abstract][Full Text] [Related]
43. Lack of correlation between repair of DNA interstrand cross-links and differential sensitivity of G0 and proliferating CD4+ lymphocytes towards cisplatin.
Bartosová Z; Horak ID; Pirsel M; Bohr VA
Neoplasma; 1999; 46(6):342-8. PubMed ID: 10732862
[TBL] [Abstract][Full Text] [Related]
44. DNA interstrand crosslinks repair in mammalian cells.
Mladenova V; Russev G
Z Naturforsch C J Biosci; 2008; 63(3-4):289-96. PubMed ID: 18533476
[TBL] [Abstract][Full Text] [Related]
45. Histone H2AX phosphorylation induced by selective photolysis of BrdU-labeled DNA with UV light: relation to cell cycle phase.
Huang X; King MA; Halicka HD; Traganos F; Okafuji M; Darzynkiewicz Z
Cytometry A; 2004 Nov; 62(1):1-7. PubMed ID: 15455410
[TBL] [Abstract][Full Text] [Related]
46. DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy.
Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR
Cancer Lett; 2006 Jul; 239(1):84-97. PubMed ID: 16143448
[TBL] [Abstract][Full Text] [Related]
47. Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks.
Banáth JP; Olive PL
Cancer Res; 2003 Aug; 63(15):4347-50. PubMed ID: 12907603
[TBL] [Abstract][Full Text] [Related]
48. The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells.
Chen P; Li J; Chen YC; Qian H; Chen YJ; Su JY; Wu M; Lan T
Cell Oncol (Dordr); 2016 Dec; 39(6):511-522. PubMed ID: 27473273
[TBL] [Abstract][Full Text] [Related]
49. p21CDKN1A allows the repair of replication-mediated DNA double-strand breaks induced by topoisomerase I and is inactivated by the checkpoint kinase inhibitor 7-hydroxystaurosporine.
Furuta T; Hayward RL; Meng LH; Takemura H; Aune GJ; Bonner WM; Aladjem MI; Kohn KW; Pommier Y
Oncogene; 2006 May; 25(20):2839-49. PubMed ID: 16407843
[TBL] [Abstract][Full Text] [Related]
50. Replication protein A and gamma-H2AX foci assembly is triggered by cellular response to DNA double-strand breaks.
Balajee AS; Geard CR
Exp Cell Res; 2004 Nov; 300(2):320-34. PubMed ID: 15474997
[TBL] [Abstract][Full Text] [Related]
51. DNA damage evaluated by gammaH2AX foci formation by a selective group of chemical/physical stressors.
Zhou C; Li Z; Diao H; Yu Y; Zhu W; Dai Y; Chen FF; Yang J
Mutat Res; 2006 Apr; 604(1-2):8-18. PubMed ID: 16423555
[TBL] [Abstract][Full Text] [Related]
52. Does gammaH2AX foci formation depend on the presence of DNA double strand breaks?
Takahashi A; Ohnishi T
Cancer Lett; 2005 Nov; 229(2):171-9. PubMed ID: 16129552
[TBL] [Abstract][Full Text] [Related]
53. Specific DNA repair mechanisms may protect some human tumor cells from DNA interstrand crosslinking by chloroethylnitrosoureas but not from crosslinking by other anti-tumor alkylating agents.
Gibson NW; Zlotogorski C; Erickson LC
Carcinogenesis; 1985 Mar; 6(3):445-50. PubMed ID: 3978757
[TBL] [Abstract][Full Text] [Related]
54. GammaH2AX foci induced by gamma rays and 125idU decay.
Yasui LS
Int J Radiat Biol; 2004; 80(11-12):895-903. PubMed ID: 15764399
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of autophagy enhances DNA damage-induced apoptosis by disrupting CHK1-dependent S phase arrest.
Liou JS; Wu YC; Yen WY; Tang YS; Kakadiya RB; Su TL; Yih LH
Toxicol Appl Pharmacol; 2014 Aug; 278(3):249-58. PubMed ID: 24823293
[TBL] [Abstract][Full Text] [Related]
56. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.
Xu ZY; Loignon M; Han FY; Panasci L; Aloyz R
J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498
[TBL] [Abstract][Full Text] [Related]
57. The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis.
Rebbaa A; Zheng X; Chu F; Mirkin BL
Cell Death Differ; 2006 Nov; 13(11):1960-7. PubMed ID: 16557274
[TBL] [Abstract][Full Text] [Related]
58. The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer.
Huang R; Langdon SP; Tse M; Mullen P; Um IH; Faratian D; Harrison DJ
Oncotarget; 2016 Jan; 7(4):4695-711. PubMed ID: 26683361
[TBL] [Abstract][Full Text] [Related]
59. Effect of cisplatin on cell death and DNA crosslinking in rat mammary. Adenocarcinoma in vitro.
Yamamoto J; Miyagi Y; Kawanishi K; Yamada S; Miyagi Y; Kodama J; Yoshinouchi M; Kudo T
Acta Med Okayama; 1999 Oct; 53(5):201-8. PubMed ID: 10561728
[TBL] [Abstract][Full Text] [Related]
60. γ-H2AX foci formation as a pharmacodynamic marker of DNA damage produced by DNA cross-linking agents: results from 2 phase I clinical trials of SJG-136 (SG2000).
Wu J; Clingen PH; Spanswick VJ; Mellinas-Gomez M; Meyer T; Puzanov I; Jodrell D; Hochhauser D; Hartley JA
Clin Cancer Res; 2013 Feb; 19(3):721-30. PubMed ID: 23251007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
